Dimensional Fund Advisors
SKYE icon

Dimensional Fund Advisors’s Skye Bioscience SKYE Stock Holding History

Dimensional Fund Advisors’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,397
Closed -$52.6K – 3338
2025
Q3 		$52.6K Buy
+13,397
New +$50.6K ﹤0.01% 3238

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Dimensional Fund Advisors's SKYE Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 13,397 shares — an estimated $52.6K sold.

Dimensional Fund Advisors first reported a position in SKYE in Q3 2025 and held it in 1 quarter. The position peaked at $52.6K in Q3 2025. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 13,397 Skye Bioscience shares in Q4 2025, an estimated $52.6K.
  • Dimensional Fund Advisors first reported a position in Skye Bioscience in Q3 2025 and held it in 1 quarter.
  • Dimensional Fund Advisors's Skye Bioscience position peaked at $52.6K in Q3 2025.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.